2024 |
10/29 | 165 | 173 | 162 | 173 | +4.85% | 339,200 | 74億9120万 | -4.42% |
10/28 | 160 | 167 | 160 | 165 | +5.77% | 311,500 | 71億4479万 | -9.34% |
10/25 | 159 | 161 | 155 | 156 | -1.89% | 461,400 | 67億5507万 | -14.75% |
10/24 | 160 | 163 | 158 | 159 | -3.05% | 335,800 | 68億8498万 | -13.59% |
10/23 | 168 | 168 | 162 | 164 | -2.96% | 392,300 | 71億148万 | -11.35% |
10/22 | 174 | 174 | 167 | 169 | -2.31% | 249,000 | 73億1799万 | -8.65% |
10/21 | 173 | 176 | 171 | 173 | +1.17% | 161,300 | 74億9120万 | -6.99% |
10/18 | 172 | 172 | 170 | 171 | -0.58% | 189,400 | 74億460万 | -8.06% |
10/17 | 173 | 175 | 171 | 172 | +0.58% | 204,500 | 74億4790万 | -8.02% |
10/16 | 173 | 174 | 169 | 171 | -2.29% | 290,100 | 74億460万 | -8.56% |
10/15 | 176 | 177 | 172 | 175 | 0% | 243,800 | 75億7780万 | -6.91% |
10/11 | 17:00 (訂正)「自社創薬パイプラインの優先度再設定及びそれに伴う上場時調達資金使途変更に関するお知らせ」の一部訂正について |
10/11 | 178 | 181 | 175 | 175 | -1.13% | 332,300 | 75億7780万 | -7.41% |
10/10 | 183 | 183 | 176 | 177 | -3.28% | 485,700 | 76億6441万 | -6.35% |
10/09 | 185 | 185 | 180 | 183 | -1.61% | 560,300 | 79億2422万 | -3.68% |
10/08 | 190 | 190 | 182 | 186 | -4.12% | 880,900 | 80億5412万 | -2.62% |
10/07 | 196 | 200 | 192 | 194 | +1.57% | 608,100 | 84億54万 | +1.57% |
10/04 | 196 | 196 | 191 | 191 | -1.04% | 391,800 | 82億7063万 | 0% |
10/03 | 198 | 198 | 193 | 193 | -1.03% | 533,700 | 83億5724万 | +0.52% |
10/02 | 211 | 211 | 195 | 195 | -6.7% | 1,248,000 | 84億4384万 | +1.56% |
10/01 | 209 | 214 | 205 | 209 | -0.48% | 939,600 | 90億5006万 | +8.85% |
09/30 | 211 | 228 | 206 | 210 | -4.11% | 2,868,300 | 90億9337万 | +9.38% |
09/27 | 193 | 235 | 193 | 219 | +14.66% | 12,033,300 | 94億8308万 | +14.66% |
09/26 | 212 | 223 | 191 | 191 | +6.7% | 11,050,100 | 82億7063万 | 0% |
09/25 | 15:00 NIB103の開発におけるタカラバイオ株式会社との業務提携に関するお知らせ |
09/25 | 181 | 184 | 179 | 179 | -1.1% | 394,600 | 77億5101万 | -6.77% |
09/24 | 189 | 191 | 181 | 181 | -2.16% | 1,283,900 | 78億3761万 | -6.22% |
09/20 | 196 | 200 | 185 | 185 | -7.96% | 2,977,800 | 80億1082万 | -4.64% |
09/19 | 184 | 206 | 180 | 201 | +7.49% | 7,958,900 | 87億365万 | +3.08% |
09/18 | 183 | 219 | 176 | 187 | +10.65% | 22,201,100 | 80億9743万 | -4.59% |
09/17 | 172 | 175 | 162 | 169 | -1.17% | 530,500 | 73億1799万 | -14.21% |
09/13 | 182 | 206 | 171 | 171 | -6.04% | 3,104,200 | 74億460万 | -12.76% |
09/12 | 187 | 190 | 182 | 182 | -0.55% | 372,700 | 78億8092万 | -7.14% |
09/11 | 187 | 192 | 183 | 183 | -2.66% | 249,400 | 79億2422万 | -6.63% |
09/10 | 187 | 192 | 187 | 188 | 0% | 208,800 | 81億4073万 | -3.09% |
09/09 | 182 | 189 | 179 | 188 | +0.53% | 274,200 | 81億4073万 | -2.08% |
09/06 | 193 | 193 | 182 | 187 | -3.11% | 467,600 | 80億9743万 | -2.6% |
09/05 | 186 | 195 | 186 | 193 | +2.12% | 371,900 | 83億5724万 | 0% |
09/04 | 193 | 195 | 188 | 189 | -5.97% | 644,900 | 81億8403万 | -3.08% |
09/03 | 198 | 203 | 195 | 201 | +2.03% | 304,700 | 87億365万 | +2.55% |
09/02 | 198 | 201 | 196 | 197 | +0.51% | 215,000 | 85億3044万 | -0.51% |
08/30 | 198 | 198 | 194 | 196 | +1.03% | 277,400 | 84億8714万 | -1.51% |
08/29 | 199 | 199 | 194 | 194 | -3% | 273,500 | 84億54万 | -3% |
08/28 | 203 | 204 | 198 | 200 | -1.96% | 463,000 | 86億6035万 | -0.99% |
08/27 | 204 | 209 | 200 | 204 | +2.51% | 594,200 | 88億3356万 | 0% |
08/26 | 194 | 203 | 193 | 199 | +1.53% | 659,600 | 86億1705万 | -3.86% |
08/23 | 200 | 202 | 193 | 196 | -2.97% | 945,600 | 84億8714万 | -6.67% |
08/22 | 207 | 209 | 202 | 202 | -1.46% | 782,200 | 87億4695万 | -5.61% |
08/21 | 209 | 215 | 205 | 205 | -3.76% | 1,021,100 | 88億7686万 | -4.65% |
08/20 | 212 | 217 | 204 | 213 | +0.47% | 2,441,400 | 92億2327万 | -0.93% |
08/19 | 206 | 239 | 200 | 212 | +4.43% | 5,925,500 | 91億7997万 | -1.4% |
08/16 | 222 | 223 | 203 | 203 | -5.14% | 1,545,300 | 87億9025万 | -5.58% |
08/15 | 220 | 224 | 203 | 214 | -1.38% | 1,975,600 | 92億6657万 | -0.93% |
08/14 | 219 | 259 | 213 | 217 | +2.84% | 12,225,600 | 93億9648万 | +0.46% |
08/13 | 162 | 211 | 162 | 211 | +31.06% | 12,995,900 | 91億3667万 | -1.86% |
08/09 | 17:45 2024年12月期第2四半期(中間期)決算短信〔日本基準〕(非連結) |
08/09 | 171 | 173 | 158 | 161 | -4.73% | 1,094,000 | 69億7158万 | -25.12% |
08/08 | 175 | 179 | 166 | 169 | -0.59% | 1,633,600 | 73億1799万 | -21.76% |
08/07 | 150 | 190 | 150 | 170 | +15.65% | 8,214,400 | 73億6130万 | -22.02% |
08/06 | 158 | 169 | 146 | 147 | +4.26% | 1,952,500 | 63億6535万 | -33.48% |
08/05 | 171 | 177 | 141 | 141 | -26.18% | 2,365,300 | 61億554万 | -36.77% |
08/02 | 197 | 202 | 188 | 191 | -7.28% | 1,400,300 | 82億7063万 | -15.49% |
08/01 | 225 | 225 | 200 | 206 | -8.44% | 1,954,100 | 89億2016万 | -9.25% |
07/31 | 235 | 238 | 225 | 225 | -4.66% | 858,900 | 97億4289万 | 0% |
07/30 | 240 | 254 | 231 | 236 | +0.85% | 2,391,100 | 102億1921万 | +5.83% |
07/29 | 230 | 240 | 224 | 234 | +2.18% | 1,408,000 | 101億3261万 | +5.88% |
07/26 | 230 | 259 | 224 | 229 | -0.43% | 4,103,800 | 99億1610万 | +5.05% |
07/25 | 237 | 249 | 216 | 230 | -6.12% | 2,431,500 | 99億5940万 | +6.48% |
07/24 | 243 | 265 | 236 | 245 | -2% | 4,324,600 | 106億893万 | +14.49% |
07/23 | 270 | 272 | 246 | 250 | -8.76% | 4,145,200 | 108億2544万 | +18.48% |
07/22 | 264 | 317 | 257 | 274 | +6.61% | 18,643,800 | 118億6468万 | +31.73% |
07/19 | 328 | 353 | 251 | 257 | -17.63% | 18,228,100 | 111億2855万 | +25.37% |
07/18 | 230 | 312 | 229 | 312 | +34.48% | 22,103,100 | 135億1015万 | +53.69% |
07/17 | 213 | 246 | 207 | 232 | +11.54% | 7,689,900 | 100億4600万 | +16% |
07/16 | 206 | 211 | 202 | 208 | +2.46% | 638,900 | 90億676万 | +4% |
07/12 | 216 | 222 | 202 | 203 | -6.45% | 1,269,800 | 87億9025万 | +1% |
07/11 | 218 | 224 | 211 | 217 | -0.46% | 927,500 | 93億9648万 | +7.96% |
07/10 | 209 | 222 | 207 | 218 | +3.32% | 1,298,400 | 94億3978万 | +10.1% |
07/09 | 206 | 230 | 201 | 211 | +2.43% | 1,850,100 | 91億3667万 | +8.21% |
07/08 | 199 | 208 | 198 | 206 | +3.52% | 636,200 | 89億2016万 | +7.29% |
07/05 | 200 | 206 | 196 | 199 | -1.49% | 640,600 | 86億1705万 | +5.29% |
07/04 | 209 | 213 | 199 | 202 | -4.72% | 1,109,800 | 87億4695万 | +8.02% |
07/03 | 225 | 228 | 210 | 212 | -7.02% | 1,504,000 | 91億7997万 | +15.22% |
07/02 | 214 | 246 | 209 | 228 | +3.64% | 3,081,900 | 98億7280万 | +26.67% |
07/01 | 223 | 257 | 220 | 220 | +10% | 7,630,000 | 95億2638万 | +25% |
06/28 | 17:00 自社創薬パイプラインの優先度再設定及びそれに伴う上場時調達資金使途変更に関するお知らせ |
06/28 | 220 | 220 | 195 | 200 | -6.54% | 1,858,400 | 86億6035万 | +16.28% |
06/27 | 174 | 223 | 174 | 214 | +22.99% | 5,617,100 | 92億6657万 | +25.88% |
06/26 | 170 | 175 | 168 | 174 | +1.75% | 382,300 | 75億3450万 | +4.82% |
06/25 | 167 | 172 | 165 | 171 | +2.4% | 456,600 | 74億460万 | +3.64% |
06/24 | 9:12 NIB102およびNIB103の武田薬品からの返還について |
06/24 | 174 | 177 | 163 | 167 | -3.47% | 966,800 | 72億3139万 | +2.45% |
06/21 | 184 | 189 | 173 | 173 | -8.47% | 1,419,900 | 74億9120万 | +6.79% |
06/20 | 170 | 199 | 170 | 189 | +9.88% | 4,117,000 | 81億8403万 | +17.39% |
06/19 | 169 | 183 | 168 | 172 | +0.58% | 1,319,800 | 74億4790万 | +7.5% |
06/18 | 181 | 181 | 168 | 171 | -5.52% | 1,420,600 | 74億460万 | +7.55% |
06/17 | 183 | 191 | 178 | 181 | -2.16% | 1,487,000 | 78億3761万 | +14.56% |
06/14 | 199 | 200 | 182 | 185 | -9.76% | 2,260,300 | 80億1082万 | +17.83% |
06/13 | 240 | 240 | 202 | 205 | -13.14% | 3,098,400 | 88億7686万 | +31.41% |
06/12 | 231 | 250 | 229 | 236 | -1.26% | 3,374,500 | 102億1921万 | +53.25% |
06/11 | 219 | 271 | 209 | 239 | +1.7% | 11,246,500 | 103億4912万 | +59.33% |
06/10 | 224 | 272 | 219 | 235 | +17.5% | 17,760,600 | 101億7591万 | +59.86% |
06/07 | 148 | 200 | 145 | 200 | +33.33% | 10,955,000 | 86億6035万 | +38.89% |
06/06 | 141 | 151 | 136 | 150 | +3.45% | 1,900,000 | 64億9526万 | +5.63% |
06/05 | 149 | 183 | 144 | 145 | +8.21% | 11,844,400 | 62億7875万 | +1.4% |